BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24440913)

  • 1. The 6th International p63/p73 Workshop: the C(ancer) and D(evelopmental) roles of p63 and p73.
    Sabapathy K; Nagakawara A; Aberdam D
    Cell Death Differ; 2014 Aug; 21(8):1340-2. PubMed ID: 24440913
    [No Abstract]   [Full Text] [Related]  

  • 2. p63 and p73: roles in development and tumor formation.
    Moll UM; Slade N
    Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of p63 and p73 antibodies for cross-reactivity.
    Rosenbluth JM; Johnson K; Tang L; Triplett T; Pietenpol JA
    Cell Cycle; 2009 Nov; 8(22):3702-6. PubMed ID: 19855172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and clinical implications of P53, P63, and P73 protein in malignant tumor of the parotid gland.
    Yong M; Yang L; Suyila Q; Han W; Yuan H; Zhao C; Su X
    Turk J Med Sci; 2014; 44(5):875-82. PubMed ID: 25539561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic prospects for p73 and p63: rising from the shadow of p53.
    Vilgelm A; El-Rifai W; Zaika A
    Drug Resist Updat; 2008; 11(4-5):152-63. PubMed ID: 18801697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
    Murray-Zmijewski F; Lane DP; Bourdon JC
    Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
    Knouf EC; Garg K; Arroyo JD; Correa Y; Sarkar D; Parkin RK; Wurz K; O'Briant KC; Godwin AK; Urban ND; Ruzzo WL; Gentleman R; Drescher CW; Swisher EM; Tewari M
    Nucleic Acids Res; 2012 Jan; 40(2):499-510. PubMed ID: 21917857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 4th International p63/p73 workshop: p53's (older) sisters take centre stage.
    Basu S; Kadakia MP
    Cell Death Differ; 2010 Mar; 17(3):562-4. PubMed ID: 19893572
    [No Abstract]   [Full Text] [Related]  

  • 9. The 5th International p63/p73 Workshop: much more than just tumour suppression.
    Kadakia MP; Caron de Fromentel C; Sabapathy K
    Cell Death Differ; 2012 Mar; 19(3):549-50. PubMed ID: 22240899
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential expression of two new members of the p53 family, p63 and p73, in extramammary Paget's disease.
    Chen S; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu Y; Furue M
    Clin Exp Dermatol; 2008 Aug; 33(5):634-40. PubMed ID: 18627398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From p63 to p53 across p73.
    Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
    FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity.
    Ory B; Ellisen LW
    Oncotarget; 2011 Mar; 2(3):259-64. PubMed ID: 21436470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
    Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
    FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo.
    Yang A; Zhu Z; Kettenbach A; Kapranov P; McKeon F; Gingeras TR; Struhl K
    PLoS One; 2010 Jul; 5(7):e11572. PubMed ID: 20644729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
    Boominathan L
    Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma].
    Zhang T; Jia H; Wang J; Shan Y; Luo S; Tang Z
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(20):919-21. PubMed ID: 19119599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p63 and p73 in retinoblastoma: a clinicopathological correlation study.
    Adithi M; Nalini V; Kandalam M; Krishnakumar S
    Exp Eye Res; 2008 Oct; 87(4):312-8. PubMed ID: 18619959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
    Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
    Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. While p73 is essential, p63 is completely dispensable for the development of the central nervous system.
    Holembowski L; Schulz R; Talos F; Scheel A; Wolff S; Dobbelstein M; Moll U
    Cell Cycle; 2011 Feb; 10(4):680-9. PubMed ID: 21293190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.